It is further reported that CD73 blockade, which has also been shown to increase the efficacy of both anti-CTLA-4 and anti-PD-L1 therapies, enhances the efficacy of radiotherapy by promoting the anti-tumor activity of the immune system (227) (228). Here, CTLA4 is linked to neoplasm.